产生CD137L-DC-EBV-VAX抗癌疫苗的方法
Emily Nickles1, Runze Xia2, Rui Sun2
1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Methods in cell biology
|March 28, 2024
概括
这项研究引入了CD137L-状细胞 (DCs) 作为癌症的强效免疫疗法. 这些由单细胞生成的新型DCs在鼻癌的临床试验中显示出优异的细胞毒性反应和改善的生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 树突细胞 (DCs) 是关键的抗原呈现细胞 (APCs),用于启动抗瘤免疫反应.
- 目前基于直流的癌症免疫疗法通常依赖于单细胞衍生直流体 (mo-DCs),由于外周血液细胞数量低,需要活体扩张.
研究的目的:
- 开发一种新的,更强大的树突细胞类型,用于癌症免疫疗法.
- 在临床前和临床环境中,评估CD137L-DCs与经典的mo-DCs相比的疗效和安全性.
主要方法:
- 从单细胞中生成CD137L-状细胞 (CD137L-DCs),使用CD137连接体激动剂.
- 在体外评估针对瘤相关病毒 (EBV,HBV) 的细胞毒性反应.
- 一期临床试验,评估 CD137L-DC-EBV 疫苗在患有鼻癌 (NPC) 的患者中.
主要成果:
- 与mo-DCs相比,CD137L-DCs在诱导细胞毒性反应方面表现出更强的功效.
- CD137L-DC-EBV疫苗在局部复发或转移性NPC.患者中表现出良好的耐受性.
- 在临床试验中观察到患者存活时间的显著延长.
结论:
- CD137L-DCs代表了癌症免疫治疗中一个有前途的新型细胞类型.
- 这些发现支持进一步开发基于CD137L-DC的疫苗,用于各种癌症,包括与病毒感染相关的癌症.
相关概念视频
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523


